Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.

The Journal of clinical endocrinology and metabolism - 1 Nov 2007

Pasquali Renato, Patton Laura, Pocognoli Patrizia, Cognigni Graciela Estela, Gambineri Alessandra

Abstract excerpt

CONTEXT: The exaggerated 17-hydroxyprogesterone response to GnRH agonists, which reflects functional ovarian hyperandrogenism (FOH), is believed to be the prominent abnormality in women with polycystic ovary syndrome (PCOS). OBJECTIVE: Our objectives were to quantify the prevalence of PCOS with FOH and to evaluate whether the presence of FOH may distinguish different clinical and biochemical phenotypes. DESIGN,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 17-alpha-Hydroxyprogesterone
Share to Anthropometry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C-Peptide

Share to Dexamethasone

Share to Gonadotropin-Releasing Hormone

Share to Hormones

Share to Hyperandrogenism

Share to Ovarian Diseases

Source

Identifiers

PMID: 17785360
DOI: 10.1210/jc.2007-0870

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.PMID 17785360Read ↗

Divergent pathophysiological drivers of polycystic ovary syndrome: insulin resistance independently fuels the hyperandrogenic phenotype whilst neuroendocrine factors dominate non-hyperandrogenic presentations.Semantic proximity Read ↗

Characterization of functionally typical and atypical types of polycystic ovary syndrome.Semantic proximity Read ↗

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes.Semantic proximity Read ↗

Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.Semantic proximity Read ↗

Clinical Phenotypes of PCOS: a Cross-Sectional Study.Semantic proximity Read ↗

The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.Semantic proximity Read ↗

Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.Semantic proximity Read ↗

Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis.Semantic proximity Read ↗

Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.Semantic proximity Read ↗

Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes.Semantic proximity Read ↗

The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.Semantic proximity Read ↗

Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.